Halting Europe’s essential medicines manufacturing exodus
European Pharmaceutical Review
FEBRUARY 2, 2023
This reliance on sourcing API from other nations puts Europe’s entire manufacturing cycle at risk, especially in the event of global crises and geopolitical tensions. This is likely to make some essential medicines and APIs economically unsustainable to manufacture.
Let's personalize your content